Your session is about to expire
← Back to Search
Rodatristat Ethyl for Healthy Subjects
Study Summary
This trial tests if a drug affects heart rhythm in healthy people.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- Your heart rate is either too slow (less than 40 beats per minute) or too fast (more than 100 beats per minute) during the screening visit or check-in.You have a history of Gilbert's Syndrome.You have had any serious illness, including viral infections, within the past 28 days before starting the study.You have a history of severe allergic reactions to rodatristat ethyl, moxifloxacin, or any similar medications.You have a past history of depression.You have any abnormal results from laboratory tests or any other medical, psychological, or social condition that could make it risky for you to participate in the study or affect the study results.You have shown signs of wanting to harm yourself or having thoughts of suicide.You have a history of certain heart problems or abnormal lab results that could increase your risk of a dangerous heart rhythm.You should avoid eating grapefruit, pomelo, Seville oranges, or drinking their juices for a week before the study and until the final lab sample is collected.
- Group 1: Rodatristat Ethyl
- Group 2: Moxifloxacin
- Group 3: Placebo for Rodatristat
- Group 4: Placebo for Moxifloxacin
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there currently opportunities for individuals to join the experiment?
"Affirmative. As per the data on clinicaltrials.gov, this research endeavour is currently accepting applicants - a trial which was first posted in May 12th 2023 and most recently updated on July 5th 2023. The study needs 64 people at one site to join up."
Does the eligibility criteria for this trial encompass individuals under 85 years old?
"Taking into account the inclusion criteria for this medical research, participants must be aged 18-55."
How many participants are currently being recruited for this medical research?
"Affirmative, the clinicaltrials.gov database outlines that this research is still recruiting volunteers. This investigation was initially posted on May 12th 2023 and recently updated on July 5th of the same year. 64 people are being sought from 1 facility for participation in this trial."
Has the FDA authorized Rodatristat Ethyl for utilization?
"Due to the limited research on rodatristat ethyl’s safety and efficacy, our team estimated it as a 1 on a scale from 1-3."
Am I able to enroll in this clinical trial?
"To be accepted into the trial, individuals must pass a physical exam and fall within the 18-55 age range. 64 participants in total will have their applications considered."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger